Life Molecular Drug Patent Portfolio
Life Molecular owns 1 orange book drug protected by 2 US patents Given below is the list of Life Molecular's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7807135 | Stilbene derivatives and their use for binding and imaging amyloid plaques | 18 Mar, 2029 | Active |
| US7907135 | Image display and image displaying method for gradation correction | 18 Mar, 2029 | Active |
Latest Legal Activities on Life Molecular's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Life Molecular.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Apr, 2022 | US7907135 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 05 Apr, 2022 | US7807135 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 Sep, 2018 | US7907135 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Apr, 2018 | US7807135 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 05 Nov, 2012 | US7807135 |
|
Correspondence Address Change
Critical
| 04 Nov, 2012 | US7807135 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Mar, 2011 | US7907135 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Mar, 2011 | US7907135 |
|
Issue Notification Mailed
Critical
| 23 Feb, 2011 | US7907135 |
| Printer Rush- No mailing | 11 Feb, 2011 | US7907135 |
|
Pubs Case Remand to TC
Critical
| 10 Feb, 2011 | US7907135 |
| Dispatch to FDC | 02 Feb, 2011 | US7907135 |
|
Application Is Considered Ready for Issue
Critical
| 28 Jan, 2011 | US7907135 |
|
Issue Fee Payment Received
Critical
| 27 Jan, 2011 | US7907135 |
|
Issue Fee Payment Verified
Critical
| 27 Jan, 2011 | US7907135 |
Life Molecular's Family Patents
Life Molecular Drug List
Given below is the complete list of Life Molecular's drugs and the patents protecting them.
1. Neuraceq
Neuraceq is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7807135 | Stilbene derivatives and their use for binding and imaging amyloid plaques |
18 Mar, 2029
(3 years from now)
| Active |
| US7907135 | Image display and image displaying method for gradation correction |
18 Mar, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neuraceq's drug page